ADAM STONE

Chief Investment Officer

In 2006 Adam Stone joined Perceptive. Prior to Perceptive he was a senior analyst at Ursus Capital. During his five years there he focused on biotech and specialty pharmaceuticals. He graduated, with honors, from Princeton University with a B.A. in molecular biology. Adam serves on the board of directors for several of Perceptive’s portfolio companies, including Solid Biosciences and Xontogeny. Additionally, Adam is a member of Perceptive’s internal investment committees for the Credit Opportunities, Venture and Discovery funds.